Evaluation of Two Daily Disposable Contact Lenses for Wearers With Astigmatism

Sponsor
CIBA VISION (Industry)
Overall Status
Completed
CT.gov ID
NCT01207466
Collaborator
(none)
95
2
30

Study Details

Study Description

Brief Summary

The purpose of this trial is to compare the performance of two contact lenses for contact lens wearers with astigmatism.

Condition or Disease Intervention/Treatment Phase
  • Device: Nelfilcon A investigational contact lens
  • Device: Nelfilcon A commercial contact lens
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
95 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Study Start Date :
Sep 1, 2010
Actual Primary Completion Date :
Oct 1, 2010
Actual Study Completion Date :
Oct 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Other: Nelfilcon A invest'l / nelfilconA comm'l

Nelfilcon A investigational toric contact lenses worn first, with nelfilcon A commercial toric contact lenses worn second. Each product worn bilaterally on a daily disposable basis for one week.

Device: Nelfilcon A investigational contact lens
Investigational, soft contact lens for astigmatism worn on a daily disposable basis.

Device: Nelfilcon A commercial contact lens
Commercially marketed, soft contact lens for astigmatism worn on a daily disposable basis.
Other Names:
  • Focus DAILIES Toric
  • Other: Nelfilcon A comm'l / nelfilconA invest'l

    Nelfilcon A commercial toric contact lenses worn first, with nelfilcon A investigational toric contact lenses worn second. Each product worn bilaterally on a daily disposable basis for one week.

    Device: Nelfilcon A investigational contact lens
    Investigational, soft contact lens for astigmatism worn on a daily disposable basis.

    Device: Nelfilcon A commercial contact lens
    Commercially marketed, soft contact lens for astigmatism worn on a daily disposable basis.
    Other Names:
  • Focus DAILIES Toric
  • Outcome Measures

    Primary Outcome Measures

    1. Quality of Vision (Crisp and Clear) [1 week of wear]

      Quality of vision (crisp and clear), as interpreted and reported by the participant by eye on a questionnaire as a single, retrospective evaluation of one week's wear time. Quality of vision was assessed on a 10-point scale, with 1 being poor and 10 being excellent.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Currently wearing soft contact lenses with astigmatism correction

    • Other protocol inclusion criteria may apply

    Exclusion Criteria:
    • Eye injury or surgery within twelve weeks prior to enrollment

    • Currently enrolled in an ophthalmic clinical trial

    • Strabismus

    • Any use of medications for which contact lens wear could be contraindicated as determined by the investigator

    • Other protocol exclusion criteria may apply

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • CIBA VISION

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    CIBA VISION
    ClinicalTrials.gov Identifier:
    NCT01207466
    Other Study ID Numbers:
    • P-415-C-001 sub 2
    First Posted:
    Sep 23, 2010
    Last Update Posted:
    Jul 10, 2012
    Last Verified:
    Jan 1, 2012
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail This reporting group includes all enrolled and dispensed participants. One participant was enrolled but not dispensed due to unacceptable fit. This participant is included in the Actual Enrollment calculation, but not Participant Flow or Baseline Characteristics calculations.
    Arm/Group Title Nelfilcon A Invest'l / nelfilconA Comm'l Nelfilcon A Comm'l / nelfilconA Invest'l
    Arm/Group Description Nelfilcon A investigational toric contact lenses worn first, with nelfilcon A commercial toric contact lenses worn second. Each product worn bilaterally on a daily disposable basis for one week. Nelfilcon A commercial toric contact lenses worn first, with nelfilcon A investigational toric contact lenses worn second. Each product worn bilaterally on a daily disposable basis for one week.
    Period Title: Period 1, One Week of Wear
    STARTED 46 48
    COMPLETED 46 48
    NOT COMPLETED 0 0
    Period Title: Period 1, One Week of Wear
    STARTED 45 48
    COMPLETED 45 48
    NOT COMPLETED 0 0

    Baseline Characteristics

    Arm/Group Title Overall
    Arm/Group Description This reporting group includes all enrolled and dispensed subjects.
    Overall Participants 94
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    35.8
    (12.2)
    Sex: Female, Male (Count of Participants)
    Female
    56
    59.6%
    Male
    38
    40.4%

    Outcome Measures

    1. Primary Outcome
    Title Quality of Vision (Crisp and Clear)
    Description Quality of vision (crisp and clear), as interpreted and reported by the participant by eye on a questionnaire as a single, retrospective evaluation of one week's wear time. Quality of vision was assessed on a 10-point scale, with 1 being poor and 10 being excellent.
    Time Frame 1 week of wear

    Outcome Measure Data

    Analysis Population Description
    Analysis conducted per protocol, with exclusions due to reasons such as: major protocol deviations as determined by masked review; discontinuations; and/or missing responses.
    Arm/Group Title Nelfilcon A Investigational Nelfilcon A Commercial
    Arm/Group Description Investigational, soft contact lenses for astigmatism worn bilaterally on a daily disposable basis for one week. Commercially marketed, soft contact lenses for astigmatism worn bilaterally on a daily disposable basis for one week.
    Measure Participants 92 91
    Measure eyes 184 182
    Mean (Standard Deviation) [units on a scale]
    8.8
    (1.3)
    8.6
    (1.5)

    Adverse Events

    Time Frame Adverse event data were collected for the duration of the trial: 45 days.
    Adverse Event Reporting Description This reporting group includes all enrolled and exposed participants.
    Arm/Group Title Nelfilcon A Investigational Nelfilcon A Commercial
    Arm/Group Description Investigational, soft contact lenses for astigmatism worn bilaterally on a daily disposable basis for one week. Commercially marketed, soft contact lenses for astigmatism worn bilaterally on a daily disposable basis for one week.
    All Cause Mortality
    Nelfilcon A Investigational Nelfilcon A Commercial
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total / (NaN) / (NaN)
    Serious Adverse Events
    Nelfilcon A Investigational Nelfilcon A Commercial
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/95 (0%) 0/93 (0%)
    Other (Not Including Serious) Adverse Events
    Nelfilcon A Investigational Nelfilcon A Commercial
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/95 (0%) 0/93 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.

    Results Point of Contact

    Name/Title Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management
    Organization CIBA VISION
    Phone 1-678-415-3343
    Email joseph.rappon@cibavision.com
    Responsible Party:
    CIBA VISION
    ClinicalTrials.gov Identifier:
    NCT01207466
    Other Study ID Numbers:
    • P-415-C-001 sub 2
    First Posted:
    Sep 23, 2010
    Last Update Posted:
    Jul 10, 2012
    Last Verified:
    Jan 1, 2012